Home/Filings/4/0001628280-24-013993
4//SEC Filing

Davis Brady 4

Accession 0001628280-24-013993

CIK 0000771856other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 3:18 PM ET

Size

10.2 KB

Accession

0001628280-24-013993

Insider Transaction Report

Form 4
Period: 2023-10-09
Davis Brady
President
Transactions
  • Award

    Option to purchase Common Stock

    2023-10-09$6.50/sh+68,000$442,000210,500 total
    Exercise: $6.50Exp: 2033-10-09Common Stock (68,000 underlying)
  • Award

    Option to purchase Common Stock

    2023-10-09$6.50/sh+135,000$877,500135,000 total
    Exercise: $6.50Exp: 2033-10-09Common Stock (135,000 underlying)
  • Award

    Option to purchase Common Stock

    2023-10-09$6.50/sh+7,500$48,750142,500 total
    Exercise: $6.50Exp: 2033-10-09Common Stock (7,500 underlying)
Footnotes (3)
  • [F1]The options vest over a four year period and are exercisable over a ten year period, with vesting to occur on October 9, 2024, October 9, 2025, October 9, 2026 and October 9, 2027, respectively.
  • [F2]The options vest fully (100%) on the one year anniversary of the date of grant and are exercisable over a ten year period, with vesting to occur on October 9, 2024.
  • [F3]The options vest over a four year period starting from the one year anniversary of the achievement of specific performance criteria and are exercisable over a ten year period.

Issuer

CHAMPIONS ONCOLOGY, INC.

CIK 0000771856

Entity typeother

Related Parties

1
  • filerCIK 0002002615

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 3:18 PM ET
Size
10.2 KB